Completed NA INTERVENTIONAL 2-arm NCT04537702

Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients

Prospective, Randomized Non-inferiority Trial of Streamlined Genetic Education and Testing for High-grade Epithelial Ovarian, Fallopian and Peritoneal Cancer Patients

Sponsor: Duke University

Conditions Fallopian Tube Cancer Ovarian Cancer, Epithelial Peritoneal Cancer

Interventions Streamlined Education Traditional Education

Updated 5 times since 2020 Last updated: Aug 25, 2021 Started: Aug 8, 2019 Primary completion: Jul 31, 2021 Completion: Jul 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Fallopian Tube Cancer and Ovarian Cancer, Epithelial, this trial is completed. The trial is conducted by Duke University and has accumulated 5 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Recruiting NA
Oct 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States